RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors.

Caption

Figure 2G. RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [⁶⁸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.

Credit

Courtesy of SNMMI.

Usage Restrictions

Please give appropriate credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.